BioSpace News Archive

Pharm Country

PDS Biotechnology Post-ASCO Conference Call Tomorrow, June 6, at 8 a.m. ET

PDS Biotechnology Corporation announced that the Company will be hosting a conference call and webcast tomorrow, June 6, 2023, to discuss the promising interim data from the VERSATILE-002 Phase 2 clinical trial investigating PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA®, presented at the 2023 American Society for Clinical Oncology meeting.

June 5, 2023
·
2 min read
Genetown

Activ Surgical® Presented Findings from Colorectal Study Using its ActivSight™ Intelligent Light at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting

Activ Surgical, a digital surgery pioneer, presented findings today at The American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting from a clinical study conducted at The Ohio State University Wexner Medical Center using the ActivPerfusion™ and ActivICG™ modes within its FDA cleared product, ActivSight™ Intelligent Light (ActivSight).

June 5, 2023
·
3 min read
Pharm Country

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Line Regimen in HR+/HER2- Advanced Breast Cancer Patients

MEDSIR announced today the results of the PALMIRA trial.

June 5, 2023
·
3 min read
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress

Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will feature theCAR-T point-of-care manufacturing platform and will present previously disclosed initial Phase 1/2 data with CD19 CAR-T candidate, GLPG5201, at the European Hematology Association (EHA) 2023 congress, taking place from 8 June to 11June 2023 in Frankfurt, Germany.

June 5, 2023
·
10 min read